Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences
About the Translational Oncology & Clinical Trials Session
Translational oncology connects laboratory discoveries with clinical applications and supports the development of new diagnostic and therapeutic approaches. This session covers the full pathway from preclinical investigation to early- and late-phase clinical trials, biomarker-driven studies, innovative trial designs, and implementation into patient care.
Abstract Scope and Participation
Submissions may include translational research, early-phase trials, randomized clinical trials, adaptive and basket trials, biomarker-driven studies, trial methodology, patient recruitment, regulatory science, and clinical implementation. Investigators, clinicians, trialists, statisticians, industry professionals, and regulatory researchers are invited.
Topics Covered in Translational Oncology & Clinical Trials
Topic 01
Translational Research
Topic 02
Early-Phase Trials
Topic 03
Clinical Trials
Topic 04
Adaptive Trial Design
Topic 05
Biomarker Trials
Topic 06
Trial Regulation
Featured Speakers — Translational Oncology & Clinical Trials 2027
Recent Research Presented at Translational Oncology & Clinical Trials Sessions
Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure human biosafety
A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based…
Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based…
Related Scientific Sessions at CIOC 2027
Why Attend the Translational Oncology & Clinical Trials Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Translational Oncology & Clinical Trials work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Translational Oncology & Clinical Trials research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Translational Oncology & Clinical Trials track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Translational Oncology & Clinical Trials Conference 2027 — FAQs
What is the Translational Oncology & Clinical Trials track at CIOC 2027?
The Translational Oncology & Clinical Trials track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Translational Oncology & Clinical Trials. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Translational Oncology & Clinical Trials sessions?
Cancer researchers and clinicians, educators and students with an interest in Translational Oncology & Clinical Trials are all welcome — whether presenting or attending.
Can I present my research in the Translational Oncology & Clinical Trials track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Translational Oncology & Clinical Trials sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Translational Oncology & Clinical Trials track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.